Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+, Mozilla Firefox 20+, Internet Explorer 11, Opera 15–18, Apple Safari 7, SeaMonkey 2.15-2.23

Become a member
  1. OncologyPRO
  2. Meeting Resources
  3. ESMO Asia Congress 2024

ESMO 2024 Highlights session 2

Locoregional hypo vs normofractionated RT in early breast cancer: 5 years results of the HypoG-01 phase III Unicancer trial

Date

07 Dec 2024

Session

ESMO 2024 Highlights session 2

Topics

Clinical Research;  Radiation Oncology

Tumour Site

Breast Cancer

Presenters

Sofia Rivera

Authors

S. Rivera

Author affiliations

  • Radiotherapy Department, Institut Gustave Roussy, 94805 - Villejuif/FR

Resources

This content is available to ESMO members and event participants.
Login

Resources from the same session

Q&A and discussion

Session: ESMO 2024 Highlights session 2

Resources:

Webcast

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings

  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.